Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/13/2025

Anesthetic Management for Hypertensive Patients Undergoing Caldwell-Luc Procedure

Pre-operative Assessment and Optimization

  • The American College of Cardiology recommends proceeding with surgery if blood pressure is less than 180/110 mmHg, as this threshold should not preclude elective surgery 1
  • Stage 1-2 hypertension (140-179/90-109 mmHg) without target organ damage does not clearly increase perioperative cardiovascular risk, according to the American Heart Association 2, 1
  • Evaluate for target organ damage (cardiac, renal, neurologic) as this is associated with increased perioperative major adverse cardiovascular events, as stated by the American Society of Anesthesiologists 2

Medication Management

  • Continue beta-blockers, calcium channel blockers, and diuretics through the morning of surgery, as recommended by the American College of Cardiology 1
  • Omit ACE inhibitors and ARBs on the day of surgery to reduce significant perioperative hemodynamic fluctuations, according to the American Heart Association 2, 1
  • Never abruptly withdraw beta-blockers as this precipitates rebound hypertension and myocardial ischemia, as warned by the American Society of Anesthesiologists 1

Induction Considerations

  • Expect pronounced sympathetic activation with laryngoscopy and intubation leading to significant blood pressure and heart rate increases, as noted by the American Society of Anesthesiologists 2, 1
  • Hypertensive patients demonstrate more labile hemodynamic profiles than normotensive counterparts, according to the American College of Cardiology 2
  • Use co-induction techniques to achieve hemodynamic stability, as recommended by the American Society of Anesthesiologists 1

Intraoperative Management

  • Maintain normotension throughout the procedure – avoid both hypotension and hypertensive responses, as recommended by the American Heart Association 2, 1
  • Optimize stroke volume with appropriate fluid therapy guided by dynamic indices, according to the American College of Cardiology 1
  • Use phenylephrine or norepinephrine for hypotension to maintain coronary perfusion pressure, as recommended by the American Society of Anesthesiologists 3, 4

Maintenance Anesthesia

  • General anesthetics are well tolerated when carefully titrated, as noted by the American College of Cardiology 3, 4
  • Maintain sinus rhythm and avoid tachycardia throughout, as recommended by the American Heart Association 3, 4
  • Use balanced anesthesia technique with volatile agent, opioid, and muscle relaxant, according to the American Society of Anesthesiologists 2

Extubation Strategy

  • Anticipate exaggerated hemodynamic response to emergence – this is more common in hypertensive patients, as warned by the American Society of Anesthesiologists 2, 1
  • Ensure adequate analgesia before emergence to blunt sympathetic response, as recommended by the American College of Cardiology 2
  • Consider prophylactic antihypertensive (labetalol, esmolol) before extubation to blunt hypertensive response, according to the American Heart Association 2

Post-Extubation Management

  • Continue invasive monitoring for 24-48 hours postoperatively as hemodynamic changes persist, as recommended by the American College of Cardiology 3, 4
  • Resume home antihypertensives (including ACE-I/ARBs) once oral intake established, according to the American Society of Anesthesiologists 1

Intraoperative Hypertension and Tachycardia Management

Primary Management Strategy

  • The American College of Cardiology/American Heart Association recommends using dedicated short-acting IV antihypertensive agents, such as clevidipine, esmolol, nicardipine, or nitroglycerin, as first-line agents for perioperative hypertension, with a strength of evidence based on high-quality randomized controlled trials 5
  • Intraoperative hypertension is most frequently seen during anesthesia induction and airway manipulation, and requires rapid BP lowering with titratable agents, according to the American College of Cardiology/American Heart Association guidelines 5
  • Continuous infusion of short-acting titratable antihypertensive agents is preferable to prevent target organ damage, as recommended by the American College of Cardiology/American Heart Association 5
  • The American College of Cardiology/American Heart Association recommends a stepwise approach to managing intraoperative hypertension, starting with addressing reversible causes, such as pain control, bladder distention, oxygenation, and volume status, before pharmacological intervention 5
  • The European Society of Cardiology recommends maintaining perioperative BP at 70-100% of baseline, avoiding both excessive peaks and profound hypotension, with a strength of evidence based on observational studies 6
  • Decreases in BP >20 mmHg for >1 hour are associated with increased complications in hypertensive patients, according to the European Society of Cardiology 6
  • Avoid excessive reduction that may cause renal, cerebral, or coronary ischemia, as recommended by the American College of Cardiology/American Heart Association 5

Common Pitfalls to Avoid

  • Rapid boluses of antihypertensive agents exacerbate hemodynamic instability in hypertensive patients, according to the European Society of Anaesthesiology 7, 8
  • Ignoring underlying causes, such as pain, light anesthesia, and sympathetic stimulation, requires specific treatment, as recommended by the American College of Cardiology/American Heart Association 5

REFERENCES

1

Management of Hypertension in Patients Undergoing Anesthesia [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025